S22-4 Pharmacokinetics and Pharmacogenomics in esophageal cancer chemoradiotherapy(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-09-15
著者
-
Sakaeda Toshiyuki
Center for Integrative Education of Pharmacy Frontier (Frontier EDucation Center)
-
Sakaeda Toshiyuki
Center For Integrative Education Of Pharmacy Frontier (frontier Education Center):graduate School Of
-
Sakaeda Toshiyuki
Center for Integrative Education in Pharmacy and Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University
関連論文
- S22-4 Pharmacokinetics and Pharmacogenomics in esophageal cancer chemoradiotherapy(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- Reversal Effects of Ca2+ Antagonists on Multidrug Resistance via Down-regulation of MDR1 mRNA
- Three-Dimensional, but not Two-Dimensional, Culture Results in Tumor Growth Enhancement after Exposure to Anticancer Drugs
- Knock-down of Sorcin Induces Up-regulation of MDR1 in HeLa Cells(Molecular and Cell Biology)
- Ligand orientation governs conjugation capacity of UDP-glucuronosyltransferase 1A1
- バルプロ酸誘発高アンモニア血症に対するCPS1 4217C>A遺伝子多型の影響
- Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting System